An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability
M. Whitlow, Jeffrey Schlom(National Cancer Institute), Steven L. Hubert, Sheau-Line Feng, Michele L. Rollence, Diane E. Milenic(National Institutes of Health), Margaret E. Schott(National Cancer Institute), Brian Bell, David Filpula, Takashi Yokota(Hokkaido University Hospital), Karl D. Hardman, James F. Wood
Cited by 308
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|973
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
|Blood|2005|896
Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors
|Hybridoma|1984|580
A spectrum of monoclonal antibodies reactive with human mammary tumor cells.
|Proceedings of the National Academy of Sciences|1981|563